Skip to content

Tinnitus implant: Tinnitus and cochlear implantation

Tinnitus implant: Tinnitus and cochlear implantation - Tinnitus and cochlear implantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON54676
Enrollment
50
Registered
2020-04-07
Start date
2021-03-09
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

moderate to severe tinnitus

Interventions

Patients from the intervention group will be surgically implanted with a CI from Cochlear Ltd under general anesthesia on the most tinnitus affected side. A phase of rehabilitation and a phase of fo

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients aged 18 or older • Seeking help for tinnitus • Subjective tinnitus • Tinnitus Functional Index (TFI) > 32 • Tinnitus duration > 1 year and subjective tinnitus stability > 6 months • Hearing level: o Audiometry (Pure Tone Average (PTA) at 0.5,1,2 kHz): bilateral threshold >= 40 and = 4 kHz) >= 50 dB o Hearing threshold stability (PTA

Exclusion criteria

Exclusion criteria: • Patient primary seeking help for non-tinnitus hearing problems • Abnormal cochlear anatomy(i.e. ossification) • Comorbidity with an expected survival of less than five years based on medical history as assessed by clinician and in electronical patient file • Additional handicaps that would prevent participation in the evaluations • Presence of any instable psychiatric condition within 6 months before start of the study • Patient with active clinical depression within the 6 months before start of the study • Unrealistic expectations on the part of the patient regarding the possible benefits, risks and limitations that are inherent to the procedure

Design outcomes

Primary

MeasureTime frame
The main outcome will be the difference of the tinnitus functional index (TFI) between the intervention (CI) at 6 months after cochlear implantation (CI) and the control group at 6 months after randomization.

Secondary

MeasureTime frame
Secondary outcome measures will be: - Anxiety and Depression level: BDI, HADS - Electrocochleography - Hearing level: pure tone audiometry at 0.25, 0.5, 1, 1.5, 2, 4 kHz - Hearing related QoL: SSQ - General QoL: EQ5D - Patient reported change: GBI and CGI - Tinnitus severity: VAS - Tinnitus pitch and loudness matching - Speech recognition test in quiet and noise The usage of CI and the hearing environment on daily average will be logged from the sound processor.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026